NRG Therapeutics
Cambridge
About NRG Therapeutics
NRG Therapeutics is a drug discovery company focused on neurodegenerative diseases. The company builds a pipeline of drug candidates aimed at restoring mitochondrial function. This therapeutic approach is designed to slow or halt the progression of diseases like Parkinson’s and ALS.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $97.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: nrgtherapeutics.com
- Phone: +44 7812 380 061
Industries & Categories
Biopharma, Biotechnology, Health Care, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nrg-therapeutics-5238 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.